Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsy

INTRODUCTION: Molecular profiling of tumor tissue is the gold standard for treatment decision-making in advanced non-small cell lung cancer (NSCLC). Results may be delayed or unavailable due to insufficient tissue, prolonged wait times for biopsy, pathology assessment and testing. We piloted the use...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Pardo, Miguel, Czarnecka, Kasia, Law, Jennifer H., Salvarrey, Alexandra, Fernandes, Roxanne, Fan, Jason, Corke, Lucy, Waddell, Thomas K., Yasufuku, Kazuhiro, Donahoe, Laura L., Pierre, Andrew, Le, Lisa W., Ghumman, Noor, Liu, Geoffrey, Shepherd, Frances A., Bradbury, Penelope, Sacher, Adrian, Stockley, Tracy, Pal, Prodipto, Rogalla, Patrik, Tsao, Ming Sound, Leighl, Natasha B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500258/
https://www.ncbi.nlm.nih.gov/pubmed/36158638
http://dx.doi.org/10.1177/17588359221126151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500258/
https://www.ncbi.nlm.nih.gov/pubmed/36158638
http://dx.doi.org/10.1177/17588359221126151

Ejemplares similares